 Jill Fattor
Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lumbar Vertebrae | 3 | 2018 | 207 | 0.610 |
Why?
| | Physical Endurance | 9 | 2013 | 232 | 0.570 |
Why?
| | Exercise | 13 | 2013 | 1641 | 0.560 |
Why?
| | Total Disc Replacement | 1 | 2016 | 14 | 0.520 |
Why?
| | Intervertebral Disc | 1 | 2016 | 36 | 0.500 |
Why?
| | Models, Anatomic | 1 | 2016 | 86 | 0.500 |
Why?
| | Lactic Acid | 7 | 2013 | 272 | 0.430 |
Why?
| | Recovery of Function | 3 | 2016 | 573 | 0.430 |
Why?
| | Lactates | 2 | 2006 | 78 | 0.250 |
Why?
| | Physical Fitness | 3 | 2013 | 180 | 0.240 |
Why?
| | Oxygen Consumption | 8 | 2013 | 587 | 0.240 |
Why?
| | Epinephrine | 2 | 2009 | 163 | 0.230 |
Why?
| | Energy Metabolism | 8 | 2010 | 727 | 0.230 |
Why?
| | Norepinephrine | 1 | 2004 | 201 | 0.220 |
Why?
| | Postmenopause | 3 | 2010 | 301 | 0.220 |
Why?
| | Gluconeogenesis | 3 | 2013 | 62 | 0.210 |
Why?
| | Muscle, Skeletal | 5 | 2007 | 1468 | 0.180 |
Why?
| | Fatty Acids, Nonesterified | 3 | 2010 | 150 | 0.160 |
Why?
| | Lipolysis | 2 | 2010 | 39 | 0.160 |
Why?
| | Blood Glucose | 5 | 2013 | 1827 | 0.150 |
Why?
| | Spondylolisthesis | 1 | 2018 | 7 | 0.150 |
Why?
| | Glycogenolysis | 3 | 2013 | 8 | 0.150 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2018 | 29 | 0.150 |
Why?
| | Antioxidants | 3 | 2006 | 529 | 0.150 |
Why?
| | Exercise Test | 6 | 2013 | 547 | 0.150 |
Why?
| | Carbon Dioxide | 3 | 2013 | 218 | 0.140 |
Why?
| | Mechanical Phenomena | 1 | 2018 | 80 | 0.140 |
Why?
| | Triglycerides | 2 | 2010 | 467 | 0.130 |
Why?
| | Finite Element Analysis | 1 | 2016 | 66 | 0.130 |
Why?
| | Spinal Fusion | 1 | 2018 | 199 | 0.130 |
Why?
| | Hypoxia | 2 | 2013 | 956 | 0.110 |
Why?
| | Glycerol | 3 | 2010 | 84 | 0.110 |
Why?
| | Physical Exertion | 2 | 2004 | 209 | 0.110 |
Why?
| | Anaerobic Threshold | 1 | 2013 | 22 | 0.110 |
Why?
| | Cardiovascular Physiological Phenomena | 2 | 2012 | 40 | 0.110 |
Why?
| | Lipid Peroxidation | 4 | 2007 | 139 | 0.110 |
Why?
| | Physical Conditioning, Human | 1 | 2013 | 27 | 0.100 |
Why?
| | Models, Biological | 2 | 2018 | 1611 | 0.100 |
Why?
| | Imaging, Three-Dimensional | 1 | 2016 | 511 | 0.100 |
Why?
| | Altitude | 2 | 2006 | 435 | 0.100 |
Why?
| | Adult | 18 | 2018 | 30395 | 0.100 |
Why?
| | Glucose | 2 | 2012 | 899 | 0.090 |
Why?
| | Oxidation-Reduction | 5 | 2013 | 917 | 0.080 |
Why?
| | Rest | 4 | 2012 | 103 | 0.080 |
Why?
| | Respiration | 1 | 2009 | 179 | 0.080 |
Why?
| | Male | 19 | 2018 | 55420 | 0.080 |
Why?
| | Insulin | 3 | 2013 | 2080 | 0.070 |
Why?
| | Fatty Acids | 2 | 2007 | 380 | 0.070 |
Why?
| | Humans | 23 | 2018 | 114080 | 0.070 |
Why?
| | Sodium Bicarbonate | 1 | 2007 | 40 | 0.070 |
Why?
| | Pulmonary Ventilation | 1 | 2007 | 72 | 0.070 |
Why?
| | Maximal Voluntary Ventilation | 1 | 2006 | 8 | 0.070 |
Why?
| | Lipid Metabolism | 2 | 2006 | 441 | 0.070 |
Why?
| | Cholesterol, HDL | 1 | 2006 | 184 | 0.060 |
Why?
| | Liver | 1 | 2012 | 1633 | 0.060 |
Why?
| | Sodium Lactate | 1 | 2004 | 5 | 0.060 |
Why?
| | Acid-Base Equilibrium | 1 | 2004 | 29 | 0.060 |
Why?
| | Kinetics | 3 | 2013 | 1547 | 0.060 |
Why?
| | Cholesterol, LDL | 1 | 2006 | 307 | 0.060 |
Why?
| | C-Reactive Protein | 1 | 2006 | 362 | 0.050 |
Why?
| | Sympathetic Nervous System | 1 | 2004 | 171 | 0.050 |
Why?
| | Muscle Contraction | 1 | 2006 | 389 | 0.050 |
Why?
| | Young Adult | 5 | 2018 | 10459 | 0.050 |
Why?
| | Altitude Sickness | 1 | 2004 | 170 | 0.050 |
Why?
| | Blood Proteins | 1 | 2004 | 222 | 0.050 |
Why?
| | Infusions, Intravenous | 3 | 2010 | 370 | 0.050 |
Why?
| | Interleukin-6 | 1 | 2006 | 673 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2006 | 1128 | 0.050 |
Why?
| | Metabolic Clearance Rate | 2 | 2013 | 102 | 0.040 |
Why?
| | Leg | 3 | 2007 | 224 | 0.040 |
Why?
| | Aging | 1 | 2010 | 1612 | 0.040 |
Why?
| | Middle Aged | 6 | 2018 | 26621 | 0.040 |
Why?
| | Palmitic Acid | 2 | 2010 | 37 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2010 | 1726 | 0.040 |
Why?
| | Carbon Isotopes | 2 | 2010 | 111 | 0.040 |
Why?
| | Oxidative Stress | 1 | 2004 | 1068 | 0.040 |
Why?
| | Apolipoproteins | 2 | 2010 | 36 | 0.040 |
Why?
| | Lumbosacral Region | 1 | 2018 | 45 | 0.040 |
Why?
| | Operative Time | 1 | 2018 | 106 | 0.040 |
Why?
| | Female | 10 | 2018 | 59349 | 0.040 |
Why?
| | Lordosis | 1 | 2018 | 12 | 0.040 |
Why?
| | Blood Loss, Surgical | 1 | 2018 | 82 | 0.040 |
Why?
| | Costs and Cost Analysis | 1 | 2018 | 196 | 0.040 |
Why?
| | Posture | 1 | 2018 | 152 | 0.040 |
Why?
| | Double-Blind Method | 3 | 2006 | 1656 | 0.040 |
Why?
| | Elective Surgical Procedures | 1 | 2018 | 150 | 0.040 |
Why?
| | Low Back Pain | 1 | 2018 | 93 | 0.030 |
Why?
| | Adolescent | 4 | 2007 | 17811 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2018 | 669 | 0.030 |
Why?
| | Regional Blood Flow | 2 | 2006 | 421 | 0.030 |
Why?
| | Body Weight | 2 | 2010 | 868 | 0.030 |
Why?
| | Sex Characteristics | 2 | 2008 | 636 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2006 | 1218 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2013 | 259 | 0.030 |
Why?
| | Pressure | 1 | 2013 | 214 | 0.030 |
Why?
| | Sex Factors | 2 | 2010 | 1707 | 0.020 |
Why?
| | Body Composition | 2 | 2006 | 590 | 0.020 |
Why?
| | Glucose Tolerance Test | 1 | 2013 | 343 | 0.020 |
Why?
| | Hormones | 1 | 2012 | 132 | 0.020 |
Why?
| | Fasting | 1 | 2012 | 242 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2371 | 0.020 |
Why?
| | Esterification | 1 | 2010 | 12 | 0.020 |
Why?
| | Diet Records | 1 | 2010 | 76 | 0.020 |
Why?
| | Walking | 1 | 2013 | 422 | 0.020 |
Why?
| | Bicycling | 1 | 2010 | 86 | 0.020 |
Why?
| | Basal Metabolism | 1 | 2009 | 46 | 0.020 |
Why?
| | Oxygen | 1 | 2013 | 851 | 0.020 |
Why?
| | Glucagon | 1 | 2009 | 92 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 2273 | 0.020 |
Why?
| | Time Factors | 2 | 2010 | 6077 | 0.020 |
Why?
| | Cholesterol | 1 | 2010 | 368 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2018 | 2122 | 0.020 |
Why?
| | Down-Regulation | 1 | 2010 | 594 | 0.020 |
Why?
| | Growth Hormone | 1 | 2007 | 103 | 0.020 |
Why?
| | Whole-Body Counting | 1 | 2006 | 4 | 0.020 |
Why?
| | Pyruvates | 1 | 2006 | 20 | 0.020 |
Why?
| | Body Weights and Measures | 1 | 2006 | 33 | 0.020 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2006 | 107 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 1 | 2006 | 117 | 0.020 |
Why?
| | Femoral Artery | 1 | 2007 | 165 | 0.020 |
Why?
| | Catecholamines | 1 | 2006 | 94 | 0.020 |
Why?
| | Lipoproteins, LDL | 1 | 2006 | 127 | 0.020 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2006 | 84 | 0.020 |
Why?
| | Hydrocortisone | 1 | 2007 | 267 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2013 | 1072 | 0.020 |
Why?
| | Workload | 1 | 2006 | 131 | 0.020 |
Why?
| | Muscle Fatigue | 1 | 2006 | 94 | 0.020 |
Why?
| | Glycolysis | 1 | 2006 | 224 | 0.010 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2006 | 185 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2018 | 9051 | 0.010 |
Why?
| | Homeostasis | 1 | 2008 | 570 | 0.010 |
Why?
| | Hematocrit | 1 | 2004 | 86 | 0.010 |
Why?
| | Placebos | 1 | 2004 | 197 | 0.010 |
Why?
| | Energy Intake | 1 | 2006 | 427 | 0.010 |
Why?
| | Heart Rate | 1 | 2006 | 710 | 0.010 |
Why?
| | DNA Damage | 1 | 2004 | 351 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2018 | 12521 | 0.010 |
Why?
| | Adaptation, Physiological | 1 | 2004 | 484 | 0.010 |
Why?
| | Body Mass Index | 1 | 2008 | 1957 | 0.010 |
Why?
| | Aged | 1 | 2018 | 18973 | 0.010 |
Why?
| | Biomarkers | 1 | 2010 | 3397 | 0.010 |
Why?
| | Diet | 1 | 2004 | 1080 | 0.010 |
Why?
| | Prospective Studies | 1 | 2006 | 6198 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2006 | 4598 | 0.010 |
Why?
| | Animals | 1 | 2006 | 31570 | 0.000 |
Why?
|
|
Fattor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|